Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects
Status:
Recruiting
Trial end date:
2022-11-27
Target enrollment:
Participant gender:
Summary
A Randomized, Open-label, Crossover Study to Evaluate the Comparative Bioavailability,
Pharmacokinetics, and Safety of GTX-102 Administered as an Oral Spray Compared to
Intramuscular Injection - betamethasone and an Oral Solution of Betamethasone in Healthy
Subjects.
Four groups of subjects will receive 2 treatments each and randomized in 2-way crossover.